CHARLES A. DINARELLO, M.D. - Corporate Board Profile

BIO-TECHNE Corp

Filing Date	Source Excerpt
2006-09-26	Charles A. Dinarello, 63 Director Professor of Medicine at 2005 the University of Colorado School of Medicine in Denver, Colorado since 1996. The Company's Board of Directors has three standing Committees, the Audit Committee, the Executive Compensation Committee and the Nominations and Governance Committee. All members of all Committees are "independent" as such term is defined in applicable law and regulations of the Securities and Exchange Commission and Nasdaq. Directors who are not employees of the Company are compensated at the rate of $25,000 per year for service on the Board and Committees of the Board.
2007-09-26	Charles A. Dinarello, 64 Director Professor of Medicine at 2005 M.D. the University of Colorado School of Medicine in Denver, Colorado since 1996.
2008-09-18	Charles A. Dinarello, 65 Director Professor of Medicine at 2005 M.D the University of Colorado School of Medicine in Denver, Colorado since 1996.
2009-09-22	Charles A. Dinarello, M.D. 66 Director Professor of Medicine at 2005 the University of Colorado School of Medicine in Denver, Colorado since 1996.
2010-09-17	Charles A. Dinarello, M.D. 25,000 99,500 124,500
2011-09-16	Charles A. Dinarello, M.D. Age: 68 Role: Director Committees: Scientific Subcommittee Compensation: $103,500 Excerpt: "Dr. Dinarello, M.D. has served on the Company’s Board since 2005..." and "2011 Director Compensation: Charles A. Dinarello, M.D., $103,500 total compensation."
2012-09-14	Charles A. Dinarello, M.D. has served on the Company 27s Board since 2005. Dr. Dinarello received his medical degree from Yale University and his clinical training at the Massachusetts General Hospital. Since 1996, Dr. Dinarello has been a Professor of Medicine and Immunology at the University of Colorado School of Medicine in Aurora, Colorado. Previously, he was Professor of Medicine and Pediatrics at Tufts University School of Medicine and a staff physician at the New England Medical Center Hospital in Boston. From March 2009 to February 2011, Dr. Dinarello served as acting CEO of Omni Bio Pharmaceutical, Inc. In 1998, Dr. Dinarello was elected to the United States National Academy of Sciences. Dr. Dinarello is considered one of the founding fathers of cytokine biology, and regularly speaks at symposia around the world. For his research in the field, Dr. Dinarello has won numerous awards: the Novartis Prize in Immunology (2010), the Paul Ehrlich Prize (2010), the Bonsfils-Staton Award (2010), the Royal Swedish Academy of Sciences Crafoord Prize in Polyarthritis (2009) and the Albany Medical Center Prize in Medical and Biomedical Research (the largest U.S. prize in medicine) (2009). Within the past five years, Dr. Dinarello has served as a director of Omni Bio Pharmaceutical, Inc. Among other attributes, skills and qualifications, the Board believes Dr. Dinarello is qualified to serve as a Director of the Company because his distinguished scientific background and his extensive experience with research organizations allow him to provide strategic guidance with regard to product development and the markets and customers we serve.
2013-09-20	Charles A. Dinarello, M.D. has served on the Company 27s Board since 2005. Dr. Dinarello received his medical degree from Yale University and his clinical training at the Massachusetts General Hospital. Since 1996, Dr. Dinarello has been a Professor of Medicine and Immunology at the University of Colorado School of Medicine in Aurora, Colorado. Previously, he was Professor of Medicine and Pediatrics at Tufts University School of Medicine and a staff physician at the New England Medical Center Hospital in Boston. From March 2009 to February 2011, Dr. Dinarello served as acting CEO of Omni Bio Pharmaceutical, Inc. In 1998, Dr. Dinarello was elected to the United States National Academy of Sciences. Dr. Dinarello is considered one of the founding fathers of cytokine biology, and regularly speaks at symposia around the world. For his research in the field, Dr. Dinarello has won numerous awards: the Novartis Prize in Immunology (2010), the Paul Ehrlich Prize (2010), the Bonsfils-Staton Award (2010), the Royal Swedish Academy of Sciences Crafoord Prize in Polyarthritis (2009) and the Albany Medical Center Prize in Medical and Biomedical Research (the largest U.S. prize in medicine) (2009). Within the past five years, Dr. Dinarello has served as a director of Omni Bio Pharmaceutical, Inc. Among other attributes, skills and qualifications, the Board believes Dr. Dinarello is qualified to serve as a Director of the Company because his distinguished scientific background and his extensive experience with research organizations allow him to provide strategic guidance with regard to product development and the markets and customers we serve.
2014-09-19	Charles A. Dinarello, M.D. has served on the Companys Board since 2005. ... Charles A. Dinarello, M.D. $217,640 total compensation.
2015-09-18	Charles A. Dinarello, M.D., age 72, has served on the Company’s Board since 2005. ... Dr. Dinarello is considered one of the founding fathers of cytokine biology. ... The Board believes Dr. Dinarello is qualified to serve as a Director of the Company because his distinguished scientific background and his extensive experience with research organizations allow him to provide strategic guidance with regard to product development and the markets and customers we serve.
2016-09-13	Charles A. Dinarello, M.D., age 73, has served on the Company’s Board since 2005. ... The Board currently has three standing Committees: the Audit Committee, the Executive Compensation Committee and the Nominations and Governance Committee. ... The membership of each standing committee during FY 2016 ... Charles A. Dinarello, M.D. is not listed as a member of any committee. ... Directors who are not employees of the Company were compensated for FY 2016 as follows: Charles A. Dinarello, M.D. total $245,312.
2017-09-12	Dr. Dinarello has been Professor of Medicine and Immunology... The Company provided products valued at less than $100,000 to a laboratory at the University of Colorado School of Medicine directed by Dr. Dinarello... Director Compensation for FY 2017: Charles A. Dinarello total $247,486.